Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Company News
Events
Directory
Search
Close search
Home
Company
Sandoz International GmbH
Sandoz International GmbH
Activities:
Pharmaceutical
X
LinkedIn
Trending Articles
How advanced technologies are unlocking the future of drug manufacturing
As the drug production landscape changes, it opens the door to pursue hybrid opportunities that push the boundaries of technological advancement in the field, reports Jon...
Actylis and Novo Nordisk Pharmatech partner for the distribution of benzalkonium chloride
The two companies aim to expand the distribution of benzalkonium chloride within Europe
Upperton opens novel development and GMP manufacturing facility
The novel 50,000 sqft development and GMP manufacturing facility in Nottingham contains ten GMP manufacturing suites, quality control laboratories and formulation development...
Astellas begins construction of manufacturing site in Tralee
600 construction jobs and 100 specialised engineering, science and technology roles will be created from the project
Policy vacuum risks UK becoming a medicines supply backwater
The UK becoming a "backwater" supply marker could jeopardise £18bn of NHS savings from newly off-patented drugs during the next five years
Upcoming event
BioProcess International Europe
9-12 April 2024 | Exhibition | RAI Amsterdam
See all
Related Content
Sustainability
Sandoz and Teva achieve independent certification for steps to minimise antimicrobial resistance risk
Certification demonstrates their commitment to protecting people and the planet
Manufacturing
Sandoz opens new packaging centre in Stryków, Poland
The generics division of Novartis has invested €42m in the project
Pharmaceutical
Nick Haggar of Sandoz to become new EGA President
Takes up the role on 8 October
Media
Asia and Latin America will drive biosimilars growth in next decade, says Visiongain
Established players will focus on monoclonal antibodies and licensing deals
Ingredients
Sandoz begins clinical trial of biosimilar rituximab
Aims to demonstrate the bioequivalence of the monoclonal antibody
Regulatory
FDA approves first generic version of Lovenox
Sanofi-aventis has reservations about Sandoz drug for treating DVT
Finance
Sandoz to acquire Oriel Therapeutics
Deal will give Sandoz rights to portfolio of respiratory products targeting asthma and COPD
Subscribe now